New Nordic Healthbrands AB (NNH) AI Stock Analysis

• Market Cap: kr140.01M
• Dividend Yield: N/A
• Average Volume (3M): 5.45K
• Price to Earnings (P/E): 28.3
• Beta (1Y): 0.17
• Revenue Growth: 3.14%
• EPS Growth: N/A
• Country: SE
• Employees: 77
• Sector: Consumer Goods
• Sector Strength: N/A
• Industry: Packaged Foods
• EPS (TTM): 0.34
• Shares Outstanding: 6,195,200
• 10 Day Avg. Volume: 3,153
• 30 Day Avg. Volume: 5,451
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: kr24.00
• Price Target Upside: 6.19% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 57 Neutral
• Price Target: kr24.00 ▲(6.19% Upside)

New Nordic Healthbrands AB shows strong revenue growth and efficient production, but faces challenges in profitability and cash conversion. The technical indicators suggest a neutral to bearish trend, and the valuation appears high relative to peers. The absence of earnings call insights and corporate events limits additional context. Overall, the stock has potential but requires operational improvements to enhance its attractiveness.

New Nordic Healthbrands AB Business Overview & Revenue Model

Company Description

New Nordic Healthbrands AB (publ) develops and markets dietary supplements, natural medicines, and cosmetic products in Sweden. The company provides vitality products for immune system. The company provides balm, repair mask, shampoo, shine serum, chewing gum, face and eye cream, and dietary supplements. It offers its products under Hair Volume, Skin Care, Beauty In & Out, and New Nordic brand names. The company sells its products through pharmacies, department stores, health stores, travel retailers, and beauty shops, as well as through online stores in 41 countries in North America, Canada, Europe, the United States, and internationally. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.

How the Company Makes Money

New Nordic Healthbrands AB generates revenue primarily through the sale of its dietary supplements and beauty products. The company's revenue model is centered on its proprietary products, which are distributed globally through a combination of direct-to-consumer sales via its online platform and through partnerships with retailers, pharmacies, and health food stores. Additionally, New Nordic's strategic marketing and brand positioning in the natural health sector contribute significantly to its earnings. The company also leverages its strong brand reputation and extensive distribution network to maintain a steady stream of income.

New Nordic Healthbrands AB Financial Statement Overview

Summary

New Nordic Healthbrands AB exhibits strong revenue growth and efficient production, as evidenced by its high gross profit margin. However, profitability is constrained by low net profit margins and modest EBIT and EBITDA margins. The balance sheet reflects a stable financial position with prudent leverage. Cash flow analysis reveals strong free cash flow growth, though challenges remain in converting earnings to cash. Overall, the company is on a growth trajectory but needs to enhance operational efficiency and cash conversion to improve profitability.

Income Statement

New Nordic Healthbrands AB shows a strong gross profit margin of 64.58% TTM, indicating efficient production and pricing strategies. However, the net profit margin is low at 0.87% TTM, reflecting challenges in controlling operating expenses. Revenue growth is robust at 37.1% TTM, suggesting strong market demand and expansion. Despite this, EBIT and EBITDA margins are modest at 1.80% and 2.30% TTM, respectively, highlighting potential inefficiencies in operations.

Balance Sheet

The company maintains a healthy debt-to-equity ratio of 0.37 TTM, indicating prudent leverage management. Return on equity is modest at 4.95% TTM, suggesting moderate profitability relative to shareholder investments. The equity ratio stands at 40.38% TTM, reflecting a stable capital structure with a significant portion of assets financed by equity.

Cash Flow

Free cash flow growth is impressive at 71.78% TTM, indicating improved cash generation capabilities. However, the operating cash flow to net income ratio is low at 0.05 TTM, suggesting potential issues in converting earnings into cash. The free cash flow to net income ratio is strong at 71.19% TTM, demonstrating effective cash management relative to earnings.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	566.00M	550.31M	533.85M	487.50M	514.85M	450.06M
Gross Profit	365.53M	354.69M	348.23M	318.50M	350.05M	309.08M
EBITDA	13.00M	-1.43M	-1.94M	-2.57M	29.34M	24.47M
Net Income	4.95M	-7.70M	-6.19M	-2.82M	21.30M	17.77M
Balance Sheet
Total Assets	252.91M	248.72M	249.06M	251.67M	238.35M	191.49M
Cash, Cash Equivalents and Short-Term Investments	9.69M	15.25M	13.81M	10.70M	11.88M	10.40M
Total Debt	37.72M	39.22M	26.64M	48.35M	24.43M	1.56M
Total Liabilities	150.79M	148.19M	143.03M	139.10M	118.03M	86.68M
Stockholders Equity	102.12M	100.92M	106.03M	112.57M	120.32M	104.81M
Cash Flow
Free Cash Flow	5.38M	-6.62M	25.88M	-18.41M	-10.58M	17.80M
Operating Cash Flow	7.56M	-5.40M	28.03M	-15.45M	-7.87M	19.68M
Investing Cash Flow	-3.96M	-3.71M	-3.40M	-2.62M	-2.97M	-1.17M
Financing Cash Flow	-5.75M	10.39M	-21.17M	16.59M	12.07M	-18.39M

New Nordic Healthbrands AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 22.60
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NNH, the sentiment is Positive. The current price of 22.6 is below the 20-day moving average (MA) of 23.06, below the 50-day MA of 23.73, and above the 200-day MA of 19.40, indicating a neutral trend. The MACD of -0.33 indicates Positive momentum. The RSI at 43.76 is Neutral, neither overbought nor oversold. The STOCH value of 26.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:NNH.

New Nordic Healthbrands AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SNX	77 Outperform	kr548.15M	31.15	―	0.50%	19.30%	68.77%
CHEF	75 Outperform	kr1.04B	22.26	―	4.16%	8.13%	90.46%
HUMBLE	59 Neutral	€3.55B	41.33	1.69%	―	6.82%	―
NNH	57 Neutral	kr140.01M	28.28	―	―	3.14%	―
Sector *	57 Neutral	$3.13B	9.23	-34.32%	3.14%	-25.56%	-353.61%
MSON.B	52 Neutral	kr1.14B	57.16	0.63%	2.54%	-2.41%	400.00%